1. Generics Bulletin
  2. >>Business
  3. >>Manufacturing

Stada Begins Work On Romanian Hub

Investment Of More Than €50m Will Strengthen Supply Chain In Europe

 
• By Dave Wallace

Stada has begun work on a facility in Romania into which the German giant is investing more than €50m to bolster the European supply chain.

Turda Romania Map Pin
Stada is investing more than €50m into the site in Turda, Romania • Source: Dmitry Kaminsky / Alamy Stock Photo

Stada has kicked off work on a supply-chain hub in Turda, Romania “to strengthen European medicines supply,” into which the German firm is investing more than €50m ($52m). The Romanian government is also “providing a sizeable state-aid contribution to the project,” Stada noted.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

Rage Against The Machine: Generics CEOs Slam Systemic Problems In The US

 
• By Dave Wallace

During the “CEOs Unplugged” panel at the AAM’s annual conference in February, leaders from Sandoz, Lupin and Amneal discussed the various ways in which the US framework is making life difficult for generics and biosimilars.

As US Launches Pharma Probe, AAM Warns Tariffs ‘Will Only Amplify Problems’

 
• By Dave Wallace

News of a fresh US investigation into the pharma sector has sparked renewed concerns over the impact that US trade tariffs would have on the generics and biosimilars industry. The AAM has responded with a warning over the potential effects on shortages and access, while Medicines for Europe has proposed five key action areas to bolster the sector in Europe.

Who’s Hired? Alvotech Appoints Strategy And Quality Chiefs

 
• By Dave Wallace

Alvotech has named two new key executives, while Biosimilars Canada has elected its 2025 leaders and the AAM has welcomed the new FDA commissioner in the US.

Sandoz And Delpharm Renew Canadian Injectables Supply Agreement For 10 Years

 
• By Dean Rudge

Along with financial backing from the Canadian government, a fresh, decade-long partnership with Sandoz Canada will allow Delpharm to carry out modernization plans for its manufacturing facility in Boucherville, securing the local supply chain for sterile injectable medicines.

More from Business